89 related articles for article (PubMed ID: 23143284)
21. Axillary lymph node dose with tangential breast irradiation.
Reed DR; Lindsley SK; Mann GN; Austin-Seymour M; Korssjoen T; Anderson BO; Moe R
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):358-64. PubMed ID: 15667953
[TBL] [Abstract][Full Text] [Related]
22. Sentinel node biopsy before neoadjuvant chemotherapy for determining axillary status and treatment prognosis in locally advanced breast cancer.
Cox CE; Cox JM; White LB; Stowell NG; Clark JD; Allred N; Meyers M; Dupont E; Furman B; Minton S
Ann Surg Oncol; 2006 Apr; 13(4):483-90. PubMed ID: 16523361
[TBL] [Abstract][Full Text] [Related]
23. Response to neoadjuvant chemotherapy in the breast predicts axillary nodal status.
Colfry AJ; Zhang X; Fuhrman GM
Am Surg; 2012 Jun; 78(6):693-7. PubMed ID: 22643266
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for sentinel lymph node metastasis and validation study of the MSKCC nomogram in breast cancer patients.
Qiu PF; Liu JJ; Wang YS; Yang GR; Liu YB; Sun X; Wang CJ; Zhang ZP
Jpn J Clin Oncol; 2012 Nov; 42(11):1002-7. PubMed ID: 23100610
[TBL] [Abstract][Full Text] [Related]
25. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
26. Identifying gaps in the locoregional management of early breast cancer: highlights from the Kyoto Consensus Conference.
Toi M; Winer EP; Inamoto T; Benson JR; Forbes JF; Mitsumori M; Robertson JF; Sasano H; von Minckwitz G; Yamauchi A; Klimberg VS
Ann Surg Oncol; 2011 Oct; 18(10):2885-92. PubMed ID: 21431404
[TBL] [Abstract][Full Text] [Related]
27. Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status.
Kuerer HM; Newman LA; Buzdar AU; Dhingra K; Hunt KK; Buchholz TA; Binkley SM; Strom EA; Ames FC; Ross MI; Feig BW; McNeese MD; Hortobagyi GN; Singletary SE
Cancer J Sci Am; 1998; 4(4):230-6. PubMed ID: 9689981
[TBL] [Abstract][Full Text] [Related]
28. Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab.
Hsiang DJ; Yamamoto M; Mehta RS; Su MY; Baick CH; Lane KT; Butler JA
Arch Surg; 2007 Sep; 142(9):855-61; discussion 860-1. PubMed ID: 17875840
[TBL] [Abstract][Full Text] [Related]
29. Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference.
Buchholz TA; Lehman CD; Harris JR; Pockaj BA; Khouri N; Hylton NF; Miller MJ; Whelan T; Pierce LJ; Esserman LJ; Newman LA; Smith BL; Bear HD; Mamounas EP
J Clin Oncol; 2008 Feb; 26(5):791-7. PubMed ID: 18258988
[TBL] [Abstract][Full Text] [Related]
30. Axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for carcinoma of the breast.
Schwartz GF; Tannebaum JE; Jernigan AM; Palazzo JP
Cancer; 2010 Mar; 116(5):1243-51. PubMed ID: 20087958
[TBL] [Abstract][Full Text] [Related]
31. Axillary staging prior to or after neoadjuvant systemic therapy? A single institutional experience.
Al Mushawah F; Tan MC; Margenthaler JA
J Surg Oncol; 2010 Oct; 102(5):404-7. PubMed ID: 20082352
[TBL] [Abstract][Full Text] [Related]
32. Axillary staging by percutaneous biopsy: sensitivity of fine-needle aspiration versus core needle biopsy.
Rao R; Lilley L; Andrews V; Radford L; Ulissey M
Ann Surg Oncol; 2009 May; 16(5):1170-5. PubMed ID: 19263171
[TBL] [Abstract][Full Text] [Related]
33. Sentinel lymph node biopsy examination for breast cancer patients with clinically negative axillary lymph nodes after neoadjuvant chemotherapy.
Kinoshita T; Takasugi M; Iwamoto E; Akashi-Tanaka S; Fukutomi T; Terui S
Am J Surg; 2006 Feb; 191(2):225-9. PubMed ID: 16442950
[TBL] [Abstract][Full Text] [Related]
34. Size of sentinel node tumor deposits and extent of axillary lymph node involvement: which breast cancer patients may benefit from less aggressive axillary dissections?
Samoilova E; Davis JT; Hinson J; Brill YM; Cibull ML; McGrath P; Romond E; Moore A; Samayoa LM
Ann Surg Oncol; 2007 Aug; 14(8):2221-7. PubMed ID: 17549569
[TBL] [Abstract][Full Text] [Related]
35. Predicting the likelihood of additional nodal metastases in breast carcinoma patients with positive sentinel node biopsy.
Mustać E; Matusan-Ilijas K; Marijić B; Smokvina M; Jonjić N
Int J Surg Pathol; 2010 Feb; 18(1):36-41. PubMed ID: 19448065
[TBL] [Abstract][Full Text] [Related]
36. Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy.
Lambert LA; Ayers GD; Meric-Bernstam F
Ann Surg Oncol; 2007 Aug; 14(8):2422-3. PubMed ID: 17514406
[No Abstract] [Full Text] [Related]
37. Conservation of the axilla: an audit of sentinel lymph node biopsy after a new start.
Apostolopoulos A; Basit A; Kirby RM; Adjogatse JK; Lambert G; Chan KY; Hancock A; Hackney L; Wall M
Clin Breast Cancer; 2011 Aug; 11(4):264-7. PubMed ID: 21715231
[TBL] [Abstract][Full Text] [Related]
38. Predictive probability of four different breast cancer nomograms for nonsentinel axillary lymph node metastasis in positive sentinel node biopsy.
Gur AS; Unal B; Johnson R; Ahrendt G; Bonaventura M; Gordon P; Soran A
J Am Coll Surg; 2009 Feb; 208(2):229-35. PubMed ID: 19228534
[TBL] [Abstract][Full Text] [Related]
39. Sentinel lymph node biopsy after neo-adjuvant chemotherapy in breast cancer.
Stell VH; Flippo-Morton TS; James Norton H; White RL
Breast J; 2011; 17(1):71-4. PubMed ID: 21129099
[TBL] [Abstract][Full Text] [Related]
40. [The role of sentinel node biopsy in breast cancer surgery].
Stańczyk M; Dziekiewicz M; Maruszyński M; Olszewski WL
Pol Merkur Lekarski; 2005 Aug; 19(110):245-8. PubMed ID: 16245445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
